Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Imagion Biosystems Ltd

IBX.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Micro Cap Analyst: N/A

Last Close

$0.01

▼ -15.38%

Market Cap $4.19M · Vol 4.97M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$4.19M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

44.44

Momentum

Beta

0.11

vs Market

52W High

$0.04

78.48% below

52W Low

$0.01

2.83% above

Volume

4.97M

Avg 1.34M

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

79.18%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Imagion Biosystems Ltd (IBX.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IBX.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-15.38%

+0.00%

-21.43%

-50.00%

YTD

-56.00%

-31.25%

-98.11%

-99.67%

Financials & Valuation

TTM · Annual

Total Revenue	$21.60K
Net Income	$-2,875,274.00
Revenue Growth (YoY)	-99.36%
Gross Margin	100.00%
Operating Margin	-10,975.08%
Net Profit Margin	-13,313.53%
ROE	N/A
ROA · ROIC	-177.79% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	214.30
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	539.94M

Technical Indicators

50-Day SMA	$0.01
200-Day SMA	$0.01
RSI (14)	44.44
Beta	0.11
52-Week High	$0.04
52-Week Low	$0.01

Volume Today	4.97M
Avg Daily Volume (30D)	1.34M
Relative Volume	3.72x
Volatility (10D)	121.64
Volatility (30D)	111.60
Free Float	79.18%

Analyst Consensus

N/A

Current Price $0.01

Mean Target N/A

52W Low$0.01 52W High$0.04

Current

Target

$0.01 $0.04

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG00GVKGY21

ISINAU000000IBX6

CountryAustralia

Sub-IndustryBio Diagnostics & Testing

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

ADPT Adaptive Biotechnologies Corp +1.14% VCYT Veracyte Inc -3.17% IOVA Iovance Biotherapeutics Inc +7.06% 300676.SZ BGI Genomics Co Ltd -3.10% CDNA CareDx Inc -4.35%

Company Profile

Imagion Biosystems Limited is a medical imaging company. The Company is developing a non-radioactive and precision diagnostic molecular imaging technology. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. It uses bio-safe magnetic nanoparticles to detect cancer and other diseases. The Company operates through Research and Development segment. Its MagSense HER2 Imaging Agent (MSH2IA) is a first-in-class molecular imaging product candidate that is intended to detect tumors more accurately than relying solely on anatomical abnormalities seen in conventional imaging. With its tumor targeting, MSH2IA produces Magnetic resonance imaging (MRI) images that are differentiable between an abnormal lymph node and a normal node in HER2 positive breast cancer patients undergoing axillary imaging. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.